Stocksigma LogoStocksigma Logo

Suraksha Diagnostic Delivers Robust Q2 FY27 Results with 69% YoY PAT Growth

Suraksha Diagnostic reported strong Q2 FY27 performance, with total income rising 26% YoY to ₹1,005.75 million and EBITDA surging 45% YoY to ₹363.17

Suraksha Diagnostic Delivers Robust Q2 FY27 Results with 69% YoY PAT Growth

Suraksha Diagnostic Ltd · Press Release · 10 Nov 2026, 10:46 pm

Suraksha Diagnostic Delivers Robust Q2 FY27 Results with 69% YoY PAT Growth Suraksha Diagnostic reported strong Q2 FY27 performance, with total income rising 26% YoY to ₹1,005.75 million and EBITDA surging 45% YoY to ₹363.17 million as EBITDA margin expanded 500 bps to 36.7%. PAT jumped 69% YoY to ₹149.50 million with a 15.1% margin. Growth was driven by a 12% YoY increase in total patients to 0.42 million and a 19% rise in average revenue per test to ₹427. For H1 FY27, revenue reached ₹1,893.09 million (up 24% YoY) with PAT of ₹277.96 million (up 54% YoY).

Original exchange filing (PDF)

More announcements from Suraksha Diagnostic Ltd

All Suraksha Diagnostic Ltd announcements